Peptide Profile
IGF-1 LR3 (Long R3-IGF-1)
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arginine 3) is a synthetic, recombinant 83-amino-acid analogue of human Insulin-like Growth Factor-1. It is primarily used in preclinical research studying cellular proliferation, muscle hypertrophy, and protein synthesis.
1. Chemical Structure and Biochemistry
Native human IGF-1 is a 70-amino-acid polypeptide. IGF-1 LR3 incorporates two targeted structural modifications:
- Arginine Substitution (R3): The glutamic acid (Glu) at position 3 is replaced with an arginine (Arg) residue.
- N-Terminal Extension (Long): A 13-amino-acid extension peptide is added to the N-terminus, bringing the total length to 83 amino acids.
2. Mechanism of Action
IGF-1 LR3 binds directly to the IGF-1 receptor (IGF-1R), activating the PI3K/Akt/mTOR and MAPK/ERK signaling cascades.
- Reduced IGFBP Binding: The R3 substitution and N-terminal extension drastically lower its affinity for endogenous IGF-Binding Proteins (IGFBPs), which normally sequester and inactivate circulating IGF-1.
- Extended Half-Life & Potency: Because it remains free in circulation, IGF-1 LR3 exhibits a prolonged half-life (reported up to 20–30 hours or more in various models) and roughly 2–3 times the biological potency of native IGF-1 in stimulating cell division and glucose uptake.
3. Research and Applications
Originally developed by GroPep to replace insulin in serum-free industrial cell cultures, its applications span biotechnology and physiological research.
- Biomanufacturing: Widely used as a supplement in mammalian cell culture to maximize recombinant protein yields and cell survival.
- Myogenesis & Recovery: Investigated in animal models for promoting satellite cell activation, skeletal muscle hyperplasia, and nitrogen retention.
Note: IGF-1 LR3 is an unapproved research reagent and is prohibited in competitive sports by WADA.
Tags:
IGF-1-LR3
Long-R3-IGF-1
insulin-like-growth-factor
recombinant-peptide
IGF-1R
mTOR
cell-proliferation
muscle-hypertrophy
cell-culture-supplement